Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 56 for “"IBC"”.
-
Optimizing the planning of IBC usage in pharmaceutical industry
An Intermediate Bulk Container (IBC) is used to contain raw materials and semi-products in pharmaceutical company ABC. Due to the high price of an IBC, company ABC sought to minimize the number of IBCs needed to support the production of four separate products. In this project, five IBCs drivers …
-
IBC management : an application of WIP control for a pharmaceutical company
An Intermediate Bulk Container (IBC) is used to contain raw materials and semi-products in pharmaceutical company ABC. Due to the high price of an IBC, company ABC sought to minimize the number of IBCs needed to support the production of four separate products. In this project, we identify five …
-
Effect of IBC isolated from Psoralea corylifolia on expression of adhesion molecule-1 in cerebrovascular endothelial cells
… Alzheimer’s disease and stroke. Isobavachalcone (IBC), a flavonoid from Psoralea corylifolia, is known to possess a wide spectrum of biological activities, antibacterial, antifungal, anticancer, anti-reverse transcriptase, antitubercular and antioxidant. Recently, it was reported that IBC …
-
Risk-Factor Induced Changes In The Breast Microenvironment Facilitate Inflammatory Breast Cancer Progression and Lymphovascular Invasion
<p>Inflammatory breast cancer (IBC) is a rapidly progressing, rare and highly lethal form of breast cancer. IBC is a clinical diagnosis, requiring >1/3 involvement on the affected breast and/or skin by erythema, and disease onset of < 6 months. The clinical symptoms of IBC vary in severity and …
-
Inflammatory Breast Cancer: The Immune Perspective
<p>Inflammatory breast cancer (IBC) is the most insidious form of locally advanced disease. Although rare and less than 2% of all breast cancer, IBC is responsible for up to 10% of all breast cancer deaths. Despite the name, very little is known about the role of inflammation or immune mediators in …
-
Gene Set Analysis of Post-Lactational Mammary Gland Involution Gene Signatures In Inflammatory and Triple Negative Breast Cancer
… to non-TN BC. Inflammatory breast cancer (IBC) accounts for approximately 1 - 5 % of all breast cancers and has significantly lower 5-year survival rates than those for non-IBC. Approximately75% of the IBC samples belongs to the more aggressive subtypes like TN, HER2-enriched, and luminal B …
-
Targeting Cox-2 and Rank In Aggressive Breast Cancers: Inflammatory Breast Cancer and Triple-Negative Breast Cancer
<p>Inflammatory breast cancer (IBC) and triple-negative breast cancer (TNBC) are two highly aggressive breast cancer subtypes associated with a poor outcome. Despite sensitivity to current treatment, these breast cancers subtypes have a high recurrence rate and proclivity to metastasize early. The …
-
Targeting Cox-2 and Rank In Aggressive Breast Cancers: Inflammatory Breast Cancer and Triple-Negative Breast Cancer
<p>Inflammatory breast cancer (IBC) and triple-negative breast cancer (TNBC) are two highly aggressive breast cancer subtypes associated with a poor outcome. Despite sensitivity to current treatment, these breast cancers subtypes have a high recurrence rate and proclivity to metastasize early. The …
-
Identification and Targeting of Therapeutic Resistance Mechanisms in Inflammatory Breast Cancer
<p>Inflammatory breast cancer (IBC) is a rare and highly aggressive form of breast cancer that is characterized by survival signaling through overexpression and/or activation of the epidermal growth factor receptors EGFR/ErbB1 and Her2/ErbB2 and defects in the apoptotic program. The development of …
-
A Novel Intrabody Communication Transceiver for Biomedical Applications
Intrabody communication (IBC) is a new physical layer defined in the recently ratified wireless body area network (WBAN) IEEE 802.15.6 standard. The cable-free IBC technology uses body tissue as a propagation medium instead of air. While recent studies have shown a degradation of transmission …
-
Preclinical Development of Therapeutic Strategies Against Triple-Negative and Inflammatory Breast Cancer
<p>Triple-negative (TNBC) and inflammatory (IBC) breast cancer are the most aggressive forms of breast cancer, accounting for 20% and 10% of cancer-related deaths, respectively. Among IBC cases, 30% are additionally classified with TNBC molecular pathology, a diagnosis that significantly worsens …
-
Role of Mir-19A Released By Inflammatory Breast Cancer Cells In The Regulation of Dendritic Cell Functions: In Vitro Model of Crosstalk In The Tumor Microenvironment of Inflammatory Breast Cancer
<p>Inflammatory breast cancer (IBC) is a rare but very aggressive form of locally advanced breast cancer (1-6% of total breast cancer patients in United States), with a 5-year overall survival rate of only 40.5%, compared with 85% of the non-IBC patients. So far, a unique molecular signature for …
-
Success and Failure Factors of Foreign Direct Investment in Transnational Education
… establishment of international branch campuses (IBC). This method provides the highest level of control but incurs the most risk, and failure can result in irrecoverable damage to reputation and substantial loss of resources. A review of the literature shows that numerous facets should be …
-
Role of shNDPK and E-Cadherin in Growth and Metastasis of an Inflammatory Breast Cancer Model (MARY-X)
MARY-X, an inflammatory breast cancer (IBC) murine xenograft, exhibits the formation of florid lymphovascular emboli in vivo and spheroid formation in vitro. IBC is highly invasive and metastatic and our model presents the same in mice as it does in human. Therefore, studying the molecular …
-
Role of X-Linked Inhibitor of Apoptosis Protein in Therapeutic Resistance of Inflammatory Breast Cancer Cells
… resistance. Inflammatory breast cancer (IBC) is a highly aggressive subtype of breast cancer that is often characterized by ErbB2 overexpression and ErbB2 activation. ErbB-targeting is clinically relevant using trastuzumab (anti-ErbB2 antibody) and lapatinib (small molecule ErbB1/2 …
-
Impacts of lateral code changes associated with the 2006 International Building Code and the 2008 California Building Code
… section of the 2006 International Building Code (IBC), which includes alterations to the procedure to determine earthquake design loading, and a drastic move to a complicated method to determine design wind pressures. The implementation of the revised 2006 International Building Code, and the …
-
Functional in vitro analyses of lipid raft-associated cathepsin b: implication for the invasive phenotype of inflammatory breast cancer
… of Philosophy</p> <p>Inflammatory breast cancer (IBC) is an aggressive, metastatic and </p> <p>highly angiogenic form of locally advanced breast cancer. Breast </p> <p>cancer invasion has been linked to proteolytic activity at the tumor </p> <p>cell surface. We observed that uPA, uPAR and …
-
Optimism, Health Locus of Control, and Quality of Life of Women with Initial versus Recurrent Breast Cancer
… women with an initial breast cancer (IBC) diagnoses and twenty-eight women with recurrent breast cancer (RBC) diagnoses were recruited from doctors' offices and cancer support groups. Correlational analyses were used to assess the relationships between variables. No significant …
-
Aspirin Use Is Associated with Improved Outcomes in Inflammatory Breast Cancer Patients
PURPOSE: Inflammatory breast cancer (IBC) is the most aggressive form of breast cancer and has a high propensity for distant metastases. Our previous data suggested that aspirin (ASA) use may be associated with reduced risk of distant metastases in aggressive BC; however, there are no reported …
Page 1 of 3